Device Trial Radar · NCT00631540
REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent
Last checked: Nov 20, 2026Latest source record: Dec 16, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Feb 2008
Primary completion
May 2010
Study completion May 2012
Sponsor
- Lead sponsor
- Cook Group IncorporatedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 7, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the safety and effectiveness of the Formula Balloon-Expandable Stent in treatment of renal artery stenosis.
Conditions
- Renal Artery Stenosis
Interventions
Formula Balloon-Expandable StentDevice
renal artery stenting
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Patency of the Treated Renal ArteryTime frame: 9 Months
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Munroe Regional Medical Center
Ocala, Florida
Orlando Regional Medical Center
Orlando, Florida
Lenox Hill Hospital
New York, New York
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.